SCHEMBL3607993

SCHEMBL3607993

Cc1cncn1-c1cccnc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.55
CYP3A4 P08684 3/20 0.55
CYP2E1 P05181 2/20 0.55
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
HTT P42858 1/20 0.42
PI4KA P42356 1/20 0.41
PI4K2B Q8TCG2 1/20 0.41
PI4K2A Q9BTU6 1/20 0.41
PI4KB Q9UBF8 1/20 0.41
ELANE P08246 1/20 0.41
AR P10275 1/20 0.40
ALOX12 P18054 1/20 0.40
EP300 Q09472 1/20 0.40
KAT2B Q92831 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNA4 P43681 1/20 0.40
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3272205 0.83 CYP3A4 (0.53) CYP3A4CYP2D6CYP2C9MAOAMAOB
SCHEMBL12349882 0.76 CYP2A6 (0.59) CYP2A6CYP3A4CYP2E1HTTELANE
SCHEMBL16040808 0.76 PI4KA (0.49) CYP2A6CYP3A4CYP2E1HTTPI4KA
SCHEMBL27989480 0.75 MAPK14 (0.47) CYP2A6CYP3A4CYP2E1HTTPI4KA
SCHEMBL4884791 0.75 CYP2A6 (0.53) CYP2A6CYP3A4CYP2E1HTTELANE
SCHEMBL27655587 0.73 MAOA (0.57) CYP3A4CYP2D6CYP2C9MAOAMAOB
SCHEMBL28030692 0.73 CYP2A6 (0.56) CYP2A6CYP3A4CYP2E1HTTPI4KA
SCHEMBL11380013 0.72 CYP3A4 (0.54) CYP3A4CYP2D6CYP2C9MAOAMAOB
SCHEMBL18500656 0.72 CYP3A4 (0.54) CYP3A4CYP2D6CYP2C9MAOAMAOB
SCHEMBL27989478 0.72 CYP11B1 (0.49) CYP2A6CYP3A4CYP2E1HTTPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609708-B2 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2013-12-17 US disclosed
US-20100298345-A1 SYNTHETIC COMPOUNDS AND DERIVATIVES AS MODULATORS OF SMOKING OR NICOTINE INGESTION AND LUNG CANCER HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2010-11-25 US disclosed
US-20080188527-A1 Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer HUMAN BIOMOLECULAR RESEARCH INSTITUTE 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188527-A1 Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer CYP2A13, CYP2A6, CYP2B6 CYP2A6 2/4885CYP3A4 45/4885CYP2E1 46/4885
US-20100298345-A1 SYNTHETIC COMPOUNDS AND DERIVATIVES AS MODULATORS OF SMOKING OR NICOTINE INGESTION AND LUNG CANCER CYP2A13, CYP2A6, CYP2B6 CYP2A6 2/4885CYP3A4 45/4885CYP2E1 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.